Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

Sanofi announced today that it has entered into an agreement to acquire Dynavax Technologies Corporation , a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B®) ...

Huonslab has entered the final stage for the commercialization of its recombinant human hyaluronidase, with the aim of receiving approval in the second half of 2026.

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an ...

The 44th J.P. Morgan Healthcare Conference will take place from January 12 to 15, 2026, in San Francisco, USA. Dr. Jason Zhu, Executive Director and Chief ...